IASLC > International Association for the Study of Lung Cancer > Conferences & Events > Event Details
Is There an Oligometastic State in NSCLC?
May 03, 2017 | Online

Overview

This webinar will feature two presentations and will be followed by a question and answer session.

In this session, the faculty will:
  • review the concept of the oligometastatic state;
  • discuss new evidence assessing the role of stereotactic radiation, and other ablative therapies, in the treatment of oligometastatic NSCLC;
  • provide a practical approach to managing patients with oligometastases;
  • examine possible combinations of radiation with targeted agents and/or immunotherapy, in patients with oligometastases;


What you should expect to learn

 After viewing this webinar, attendees will be able to:

  • describe the current status of SBRT for the treatment of oligometases;
  • identify novel treatment recommendations for the management of patients with oligometastases;
  • illustrate current clinical trials enrolling patients with oligometastatic disease.

Program Chair

Laurie E. Gaspar, MD, FASTRO, FACR, MBA 
Grohne Chair in Clinical Oncology
Department of Radiation Oncology,
University of Colorado School of Medicine Denver, Colorado USA

&

Joe Y. Chang, MD, PhD

Professor and Clinical Section
Chief of Thoracic Radiation Oncology
UT MD Anderson Cancer Center, USA 

&

Dr. David Palma, MD, MSc, FRCPC, PhD

Radiation Oncologist, 
London Health Sciences Centre
Clinician-Scientist,
Ontario Institute for Cancer Research

Contact